[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349419-105":59,"doc-detail-349419-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","human-papilloma-virus-hpv-prevalence-and-genotype-distribution-among-women-in-karachi-pakistan","Human Papilloma Virus (HPV) prevalence and genotype distribution among women in Karachi, Pakistan","","Human papillomavirus (HPV) epidemiological data from Pakistan remain limited, especially for unscreened and unvaccinated populations. A cross-sectional study in Karachi (May 2022–November 2023) analyzed cervical samples from 497 consenting women out of 3119 invited participants. HPV detection and genotyping used INNO-LiPA HPV Genotyping Extra II line probe assay. Overall HPV prevalence was 16.7%, with 11.8% high-risk and 5.0% low-risk or unclassified types. High-risk peaks occurred at ages 25–34 (21.4%) and remained detectable above 54 (12.5%).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/human-papilloma-virus-hpv-prevalence-and-genotype-distribution-among-women-in-karachi-pakistan/349419/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/human-papilloma-virus-hpv-prevalence-and-genotype-distribution-among-women-in-karachi-pakistan/349419.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of the Karachi study on HPV?","Question",{"text":112,"@type":113},"To determine overall type- and age-specific HPV prevalence among women in Karachi, Pakistan, over May 2022 to November 2023.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were HPV infections detected and genotyped?",{"text":117,"@type":113},"HPV detection and genotyping were performed using the INNO-LiPA HPV Genotyping Extra II line probe assay.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key HPV prevalence findings by risk category?",{"text":121,"@type":113},"Overall HPV prevalence was 16.7%. High-risk types were found in 11.8% of women, and low-risk or unclassified types in 5.0%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349419,1790647711,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Journal of Virus Eradication 12 (2026) 100631  \nContents lists available at ScienceDirect  \nJournal of Virus Eradication  \njournal [homepage:](homepage: www.sciencedirect.com/journal/journal-of-virus-eradication)[ www.sciencedirect.com/journal/journal-of-virus-eradication](homepage: www.sciencedirect.com/journal/journal-of-virus-eradication)  \nOriginal research  \nHuman Papilloma Virus (HPV) prevalence and genotype distribution among women in Karachi, Pakistan  \nS. Maria Jilani a,d, Angelika Iftner c,d, Hana'a Iqbal a , Atia Tul-Wahaba,b,  \nM. Iqbal Choudhary a,b, Sharmeen Fayyaza,*, Tina M. Rehmc, Thomas Iftnerc,**   \na National Institute of Virology, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, 75270, Pakistan  \nb Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, 75270, Pakistan  \nc Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, 72076, Tübingen, Germany  \n\n| A B S T R A C T |\n| --- |\n| Human papillomavirus (HPV) epidemiological data from Pakistan remain limited, particularly in unscreened and unvaccinated populations. We performed a crosssectional study in Karachi, Pakistan, to determine overall type- and age-specific HPV prevalence between May 2022 and November 2023. A total of 3119 women were invited to participate; 497 women gave consent, provided cervical samples and were included in the final analysis. HPV detection and genotyping were done using the highly sensitive INNO-LiPA HPV Genotyping Extra II line probe assay. Overall HPV prevalence was 16.7%. High-risk (HR) HPV types (counted once per genotype within IARC groups 1, 2A and 2B) were detected in 11.8% of women, and low-risk or unclassified types in 5.0%. Single HR-HPV infections occurred in 8.4% and multiple HR-HPV infections in 3.4%. Fourteen HR genotypes were detected as single infections, with HPV31 and HPV53 (1.2% each) being most prevalent, followed by HPV68 (1.0%), HPV16 (0.8%), and HPV33/HPV39/HPV51 (0.6% each). Less frequent types included HPV82 and HPV18 (0.4% each), and HPV35/ HPV70/HPV73 (0.2% each). The most prevalent low-risk type was HPV6 (1.2%). HPV prevalence peaked in women aged 25-34 years (21.4%) and remained detectable in women above 54 years (12.5%). These data indicate a substantial and genetically diverse HR-HPV burden in Karachi. They support organized HPVbased cervical cancer screening using high-performance assays that detect the full panel of carcinogenic HPV types, with adequate triage and follow-up. They also support rapid scale-up and monitoring of HPV vaccination in Pakistan, including assessment of broader-valency vaccination strategies where feasible, to reduce cervical cancer, pre-cancerous lesions and other HPV-related cancers. |\n\n1. Introduction  \nCervical cancer is the fourth most common cancer in women worldwide and the second most common cancer in women of reproductive age. With 662301 new cases and 348874 deaths worldwide in 2022, cervical cancer is a global health burden.1,2 It is particularly prevalent in developing countries, where about 85% of cervical cancer cases are diagnosed. In many developed countries, the incidence of cervical cancer has declined in recent decades following the introduction of organized cervical cancer screening programs using cervical cytology.3 In contrast, the incidence of cervical cancer remains high in developing countries because of a lack of organized screening and a high prevalence of risk factors for cervical neoplasia, particularly infection with high-risk human papillomavirus (HR-HPV) and co-infection with human immunodeficiency virus (HIV). Persistent infection with high  \nrisk HPV types (HR) has been identified as a necessary risk factor in the development of cervical cancer.2,4 Pakistan is the 5th most populous c","cbCaio0X0ihPkg4t","https://ap.wps.com/l/cbCaio0X0ihPkg4t","pdf",2418425,"English","# Introduction\n## Study results: HPV prevalence by risk category and genotype\n## Age-specific HPV prevalence\n## Implications for screening and vaccination","[{\"question\":\"What was the purpose of the Karachi study on HPV?\",\"answer\":\"To determine overall type- and age-specific HPV prevalence among women in Karachi, Pakistan, over May 2022 to November 2023.\"},{\"question\":\"How were HPV infections detected and genotyped?\",\"answer\":\"HPV detection and genotyping were performed using the INNO-LiPA HPV Genotyping Extra II line probe assay.\"},{\"question\":\"What were the key HPV prevalence findings by risk category?\",\"answer\":\"Overall HPV prevalence was 16.7%. High-risk types were found in 11.8% of women, and low-risk or unclassified types in 5.0%.\"}]","Human Papilloma Virus (HPV) prevalence and genotype distribution among women in Karachi, Pakistan | PDF",1790083214,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bbe9dadb7bb4875f821110df5da72422.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9ef88eee047fc7ddd96f9801d97ed8d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fa834c793d8fff3b533def9f5aa53c9.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfa2c1a4fc746f7e403e02fcda49ee1e.webp",980,1306]